Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption.
Nature. 2016 Jul 28;535(7613):556-60. doi: 10.1038/nature18929. Epub 2016 Jun 22.
Nature. 2016.
PMID: 27338952
Free PMC article.
Clinical Trial.
High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function.
Foley MH, Forcier T, McAndrew E, Gonzalez M, Chen H, Juelg B, Walker BD, Irvine DJ.
Foley MH, et al. Among authors: juelg b.
PLoS One. 2014 Feb 13;9(2):e87873. doi: 10.1371/journal.pone.0087873. eCollection 2014.
PLoS One. 2014.
PMID: 24551068
Free PMC article.
Item in Clipboard
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team.
O'Brien MP, et al.
JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939.
JAMA. 2022.
PMID: 35029629
Free PMC article.
Clinical Trial.
Item in Clipboard
Antibody-Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers.
Leonard EK, Aller Pellitero M, Juelg B, Spangler JB, Arroyo-Currás N.
Leonard EK, et al. Among authors: juelg b.
J Am Chem Soc. 2022 Jun 29;144(25):11226-11237. doi: 10.1021/jacs.2c02537. Epub 2022 Jun 8.
J Am Chem Soc. 2022.
PMID: 35675509
Free PMC article.
Item in Clipboard
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022.
Atyeo C, Slein MD, Fischinger S, Burke J, Schäfer A, Leist SR, Kuzmina NA, Mire C, Honko A, Johnson R, Storm N, Bernett M, Tong P, Zuo T, Lin J, Zuiani A, Linde C, Suscovich T, Wesemann DR, Griffiths A, Desjarlais JR, Juelg BD, Goudsmit J, Bukreyev A, Baric R, Alter G.
Atyeo C, et al. Among authors: juelg bd.
JCI Insight. 2021 Jan 11;6(1):e143129. doi: 10.1172/jci.insight.143129.
JCI Insight. 2021.
PMID: 33427208
Free PMC article.
Item in Clipboard
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team.
O'Brien MP, et al.
N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4.
N Engl J Med. 2021.
PMID: 34347950
Free PMC article.
Clinical Trial.
Item in Clipboard
Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination.
Roy V, Jung W, Linde C, Coates E, Ledgerwood J, Costner P, Yamshchikov G, Streeck H, Juelg B, Lauffenburger DA, Alter G.
Roy V, et al. Among authors: juelg b.
NPJ Vaccines. 2023 Mar 15;8(1):39. doi: 10.1038/s41541-023-00628-8.
NPJ Vaccines. 2023.
PMID: 36922512
Free PMC article.
Item in Clipboard
Cite
Cite